Enzymatica AB (publ)
STO: ENZY.ST0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Stockholm Stock Exchange
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Sana Alajmovic
- Employees
- 21
- Headquarters
- Lund, Sweden
- IPO year
- 2011
- Market cap
- SEK 650.5M
- Website
- https://www.enzymatica.se
Loading ENZY…
Loading profile data…Frequently asked questions about ENZY
What does Enzymatica AB (publ) (ENZY.ST) do?
Enzymatica AB, a life science company, develops and sells medical devices for infection-related diseases. The company's product includes ColdZyme mouth spray, which prevents common cold and reduces the duration of illness. It also provides enzyme formulations. The company sells mouth spray under the ViruProtect brand in Denmark; STADAProtect bra...
Where does ENZY.ST trade?
Enzymatica AB (publ) (ENZY.ST) trades on the Stockholm Stock Exchange.
What sector is ENZY.ST in?
Enzymatica AB (publ) (ENZY.ST) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of Enzymatica AB (publ)?
Sana Alajmovic is the chief executive officer of Enzymatica AB (publ) (ENZY.ST).
Where is Enzymatica AB (publ) headquartered?
Enzymatica AB (publ) is headquartered in Sweden.
Does ENZY.ST pay a dividend?
Enzymatica AB (publ) (ENZY.ST) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did ENZY.ST go public?
Enzymatica AB (publ) (ENZY.ST) completed its initial public offering in 2011.